regulatory
confidence high
sentiment positive
materiality 0.75
MAXCYTE, INC. (MXCT): Nasdaq/NYSE listing notice — MaxCyte regains compliance with Nasdaq $1.00 bid price rule
MAXCYTE, INC.
- Received Nasdaq notice on June 10, 2026 that closing bid price has been ≥$1.00 for 10 consecutive business days (May 27 – June 9, 2026).
- Compliance with Listing Rule 5450(a)(1) is now regained; delisting matter is closed.
- Previously disclosed receipt of deficiency notice on March 16, 2026 for bid price below $1.00 for 30 consecutive days.